Why Eli Lilly Stock Is Soaring Today
Published
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation.
Full ArticlePublished
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation.
Full ArticleBiogen's stunning win of FDA approval for aducanumab spurred investors' excitement about Lilly's prospects for its Alzheimer's..